AcquisitionOther
Merck KGaA acquired SpringWorks Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Merck KGaA -> SpringWorks Therapeutics · approximately $3.9 billion
Acquisition to strengthen Merck KGaA's Healthcare business presence in the United States and expand reach for rare tumor therapies worldwide.
Open source record (SEC) ↗